The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Vanlent Anne since year 2005.
The trader's CIK number is 1229243.
At the time of this reporting, Vanlent Anne is the Director of Nabi Biopharmaceuticals .
(stock ticker symbol NABI).
See this page for all insider trading activities at Nabi Biopharmaceuticals .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-05-08||AEGR||Aegerion Pharmaceuticals, Inc.||Buy||4,000||34.27||137,092|
|2011-01-13||IART||Integra Lifesciences Holdings Corp||Sale||5,270||47.49||250,277|
|2011-01-13||IART||Integra Lifesciences Holdings Corp||Option Ex||7,500||33.32||249,900|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vanlent Anne (Director of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.